Immune thrombocytopenia after immune checkpoint inhibitor therapy

被引：4

作者：

Amanam, Idoroenyi ^{[1
]}

Gupta, Rohan ^{[2
]}

Pullarkat, Vinod ^{[1
]}

Mei, Matthew ^{[1
]}

机构：

[1] City Hope Natl Med Ctr, Dept Hematol & HCT, Duarte, CA 91010 USA

[2] CenterTX, Dallas, TX USA

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷 / 03期

关键词：

D O I：

10.1111/bjh.17387

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：677 / 681

页数：5

共 37 条

[1] Development of thrombocytopenia is associated with improved survival in patients treated with immunotherapy [J].

Assi, Hussein A. ;

Asch, Adam S. ;

Machiorlatti, Michael ;

Vesely, Sara K. ;

Ibrahimi, Sami .

FUTURE SCIENCE OA, 2020, 6 (07)

[2]

AstraZeneca Pharmaceuticals LP, IMFINZI DURV

[3]

Atay MH, 2015, J BUON, V20, P1641

[4] Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline [J].

Brahmer, Julie R. ;

Lacchetti, Christina ;

Schneider, Bryan J. ;

Atkins, Michael B. ;

Brassil, Kelly J. ;

Caterino, Jeffrey M. ;

Chau, Ian ;

Ernstoff, Marc S. ;

Gardner, Jennifer M. ;

Ginex, Pamela ;

Hallmeyer, Sigrun ;

Chakrabarty, Jennifer Holter ;

Leighl, Natasha B. ;

Mammen, Jennifer S. ;

McDermott, David F. ;

Naing, Aung ;

Nastoupil, Loretta J. ;

Phillips, Tanyanika ;

Porter, Laura D. ;

Puzanov, Igor ;

Reichner, Cristina A. ;

Santomasso, Bianca D. ;

Seigel, Carole ;

Spira, Alexander ;

Suarez-Almazor, Maria E. ;

Wang, Yinghong ;

Weber, Jeffrey S. ;

Wolchok, Jedd D. ;

Thompson, John A. .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (17) :1714-+

[5]

Bristol-Myers Squibb Company, OPDIVO NIV

[6]

Bristol-Myers Squibb Company, YERVOY IP

[7] Hematological Side Effects of Immune Checkpoint Inhibitors: The Example of Immune-Related Thrombocytopenia [J].

Calvo, Roser .

FRONTIERS IN PHARMACOLOGY, 2019, 10

[8] Nivolumab-induced aplastic anemia: A case report and literature review [J].

Comito, Rachel R. ;

Badu, Lynette A. ;

Forcello, Nicholas .

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (01) :221-225

[9]

Delaney N, 2019, LANCET HAEMATOL, V6, pE48, DOI [10.1016/S2352-3026(18)30175-3, 10.1016/52352-3026(18)30175-3]

[10] Pembrolizumab-induced thrombotic thrombocytopenic purpura [J].

Dickey, Marcus S. R. ;

Raina, Anant J. ;

Gilbar, Peter J. ;

Wisniowski, Brendan L. ;

Collins, Joel T. ;

Karki, Bhaskar ;

Nguyen, Andrew D. k .

JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2020, 26 (05) :1237-1240

← 1 2 3 4 →